These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 789040)

  • 1. [Chronic active (aggressive) hepatitis. Differential diagnosis of lupoid (ANA-positive) and cholestatic (AMA-positive) hepatitis].
    Berg PA
    Dtsch Med Wochenschr; 1976 Oct; 101(42):1536-43. PubMed ID: 789040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W; Emmrich R; Petzold H
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory tests for diagnosis of autoimmune diseases.
    Nakamura RM; Chisari FV; Edgington TS
    Prog Clin Pathol; 1975; 6():177-203. PubMed ID: 1105671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoserologic differentiation of chronic cholestatic hepatitis. Significance of antimitochondrial antibodies and hepatic membrane antibodies].
    Hopf U; Möller B; Lobeck H; Klein R; Berg PA
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1924-9. PubMed ID: 3908047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathogenesis of chronic inflammatory liver diseases].
    Meyer zum Büschenfelde
    Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Australia antigen in chronic aggressive hepatitis and liver cirrhosis. Its significance for the etiology and pathogenesis of chronic inflammatory liver diseases].
    Müller R; Kalden JR; Baruth B; Deicher H
    Dtsch Med Wochenschr; 1972 Mar; 97(10):369-75. PubMed ID: 4622158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of high titers of various autoantibodies in the diagnosis and monitoring of chronic liver diseases].
    Ninova-Bradistilova D; Naumov N; Krustev Z; Ognianov M; Maleev A
    Vutr Boles; 1983; 22(6):46-52. PubMed ID: 6608830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R; Farini R; Chiaramonte M
    Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of anti-tissue antibodies in the evolution of chronic liver diseases].
    Buligescu L; Moscaliuc I; Eşanu I; Ionică M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(6):445-52. PubMed ID: 6121363
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification and diagnosis of chronic hepatitis].
    Fehér J; Jakab L; Réffy A
    Z Arztl Fortbild (Jena); 1973 Feb; 67(3):113-7. PubMed ID: 4572676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Autoantibodies and Australia antigen in acute and chronic liver].
    Fargion SR; Del Ninno E; Cappellini MD; Fiorelli G
    Minerva Med; 1974 Feb; 65(13):723-8. PubMed ID: 4545217
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possible use of immunofluorescence in chronic agressive hepatitis].
    Storch W; Emmrich R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(3):119-23. PubMed ID: 4599279
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
    Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative alterations of the immunoglobuline classes and the presence of autoantibodies in liver diseases (author's transl)].
    Ossena A; Gola F; Raho L; Taroni G
    Quad Sclavo Diagn; 1978 Sep; 15(3):316. PubMed ID: 379904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies against mitochondria, smooth muscle and nuclei in chronic liver diseases].
    Hauftová D; Macák J
    Vnitr Lek; 1976 Dec; 22(12):1185-91. PubMed ID: 1087498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heterogeneity of mitochondrial antibodies (AMA): significance of the demonstration of AMA antibodies in chronic aggressive hepatitis with cholestasis].
    Berg PA; Binder T; Breitsohl-Mörk C; Lindner H; Bannaski H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1833-6. PubMed ID: 70901
    [No Abstract]   [Full Text] [Related]  

  • 18. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
    Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
    Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic specificity of autoantibodies. II. Clustering of autoantibodies--role in diagnosis and in comparison to E--and EAC-RFC peripheral blood profiles and immunoglobulin levels.
    Lange A; Smolik R; Chmielarczyk W; Garncarek D; Gielgier Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):881-5. PubMed ID: 312092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.